Janssen’s Topamax Users Blame Drug for Birth Defects
This article is for subscribers only.
Johnson & Johnson’s Janssen Pharmaceuticals failed to inform expectant mothers of risks that its epilepsy drug Topamax could cause birth defects, a lawyer for the mother of a 6-year-old in Virginia told a jury.
April Czimmer wouldn’t have taken Topamax for more than six months had she known the risks associated with the drug, her attorney Tommy Fibich said in opening statements today in state court in Philadelphia.